There is no single, permanent cure for insomnia in the way antibiotics cure an infection. But insomnia can be effectively treated, and many people reach full remission where they sleep normally again. About 42% of people with insomnia naturally stop meeting diagnostic criteria over time, and structured treatment pushes those numbers considerably higher. The distinction matters: insomnia is less like a disease you eliminate and more like a pattern you can break, though it sometimes returns.
What Remission Actually Looks Like
Sleep researchers distinguish between two types of recovery. “Asymptomatic remitters” are people who no longer have trouble sleeping and fall asleep within 30 minutes, with minimal waking during the night. “Symptomatic remitters” technically no longer meet diagnostic criteria but still take more than 31 minutes to fall asleep or spend that long awake in the middle of the night. In one study tracking 649 people with insomnia, about 42% reached remission at follow-up. But of those remitters, two-thirds still had objectively poor sleep. They simply stopped being as bothered by it.
That’s a meaningful finding. It means some people “recover” from insomnia not because their sleep dramatically improves, but because they develop greater tolerance for disrupted sleep and it stops interfering with their daily life. The people who truly normalized their sleep, the asymptomatic remitters, showed the biggest gains in daytime energy and functioning. So the goal of treatment isn’t just to feel okay about bad sleep. It’s to actually sleep better.
The Most Effective Treatment Available
Cognitive Behavioral Therapy for Insomnia, known as CBT-I, is the first-line treatment recommended by every major sleep medicine organization. It works without medication, and it outperforms sleeping pills over the long term because it addresses the mental and behavioral patterns that keep insomnia going.
A typical course runs 6 to 8 weekly sessions. It combines several techniques: restricting time in bed to match how much you actually sleep, reassociating the bed with sleep rather than wakefulness, and restructuring the anxious thoughts about sleep that fuel the cycle. The results are strong. Between 70% and 80% of people who complete the full course see meaningful improvement, and about 40% achieve clinical remission. Many people notice a shift within the first four weeks.
The challenge is access. There aren’t enough trained CBT-I therapists to meet demand. Digital versions can help bridge the gap. The app Somryst (now called Pear-004) is the only FDA-cleared digital CBT-I program in the U.S., available by prescription. It delivers the same core components (sleep restriction, stimulus control, cognitive restructuring) through a 9-week automated program. It’s not identical to working with a therapist, but the American Academy of Sleep Medicine suggests it as a reasonable starting point when in-person treatment isn’t available.
Why Your Insomnia Might Have a Treatable Cause
About 40% of people with insomnia also have a psychiatric condition, most commonly depression or anxiety. In these cases, insomnia and the underlying condition feed each other. Treating only the insomnia without addressing depression, for instance, often leads to incomplete recovery. The reverse is also true: treating depression alone doesn’t always fix the sleep problem.
Other medical conditions that commonly disrupt sleep include restless legs syndrome, sleep apnea, chronic pain, and thyroid disorders. If your insomnia started alongside another health change, or if you snore heavily, wake gasping, or have an irresistible urge to move your legs at night, the insomnia may resolve once the root cause is treated. This is the closest thing to a “cure” in the traditional sense: remove the trigger, and the sleep problem disappears.
Where Medication Fits In
Sleep medications are designed for short-term use, typically a few days to a few weeks. They can be helpful during an acute crisis, like insomnia triggered by grief, jet lag, or a medical procedure, but they don’t address the underlying patterns that sustain chronic insomnia.
Older sleep drugs work by broadly sedating the brain, which is why they tend to come with side effects like grogginess, dependence, and rebound insomnia when you stop. A newer class of medications works differently. These drugs block orexin, a chemical your brain uses specifically to promote wakefulness. By targeting only the wake signal rather than sedating the whole brain, they cause fewer side effects. But they’re still not considered a long-term solution on their own, and they don’t retrain the sleep habits and thought patterns that CBT-I addresses.
Supplements: What the Evidence Shows
Melatonin and magnesium are the two most popular over-the-counter options. Melatonin can help with circadian rhythm issues, like when your body clock is shifted later than your schedule requires, but the evidence for it as a treatment for general chronic insomnia is modest.
Magnesium has slightly more interesting data. In a controlled trial of elderly adults with insomnia, 500 mg of magnesium daily for 8 weeks improved sleep efficiency, reduced the time it took to fall asleep, and lowered the stress hormone cortisol compared to placebo. However, total sleep time didn’t show a statistically significant difference between groups. Magnesium appears to help people who are deficient in it (which is relatively common in older adults), but it’s unlikely to resolve chronic insomnia on its own.
Sleep Hygiene Alone Isn’t Enough
Keeping a consistent wake time, avoiding screens before bed, limiting caffeine after noon, keeping the bedroom cool and dark: these are all reasonable habits. And there is evidence that sleep hygiene practices improve sleep quality. But for someone with established chronic insomnia, sleep hygiene alone rarely resolves the problem. It’s better understood as a foundation that makes other treatments more effective. If you’ve already optimized your sleep environment and habits and you’re still struggling, that’s a sign you need a more structured intervention like CBT-I.
Relapse Is Common but Manageable
Insomnia tends to wax and wane over a lifetime. Even after successful treatment or natural remission, roughly 27% of people relapse within three years. In a longer study tracking people over four years after remission, 248 out of 434 participants experienced at least some return of symptoms.
Certain factors predict who’s more likely to relapse. Residual difficulty staying asleep (as opposed to trouble falling asleep) is one. Daytime fatigue, mood disturbances, and concentration problems that linger after remission are others. Women face a slightly higher relapse risk than men, and the triggers differ by sex: for men, residual cognitive fog and overall sleep quality are the strongest predictors, while for women, nighttime waking combined with mood and concentration issues matter more.
This is precisely why CBT-I has an advantage over medication. The skills it teaches, like breaking the mental association between the bed and wakefulness, or knowing how to compress your sleep window during a rough stretch, remain available to you long after treatment ends. People who complete CBT-I can essentially re-apply the techniques if symptoms return, often heading off a full relapse before it develops. Insomnia may not have a one-time cure, but it is one of the most treatable sleep disorders when approached with the right tools.